Search
AC Immune SA
ACIUAdd to Watchlist
2.250USD
-0.060-2.60%
Close 10-27 16:00（ET）
228.98MMarket Cap
LossP/E TTM
AC Immune SA (ACIU) Stock Price Target & Forecast
Analyst Rating
Based on 4 analysts giving stock ratings to AC Immune SA in the past month.
Strong Buy
3 Strong Buy
1 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
9.113USD+294.49%
ACIU Analyst Recommendation Trends
In the current month, ACIU has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ACIU average Analyst price target in the last month is 9.113.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
3
3
3
3
3
3
3
3
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
4
4
4
4
4
4
4
ACIU Analyst Rating for Peer Comparison
Updated: Oct 27, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Biogen Inc
BIIB
9
17
11
1
0
38
Amgen Inc
AMGN
4
9
19
3
1
36
Eli Lilly and Co
LLY
10
19
3
1
0
33
Vertex Pharmaceuticals Inc
VRTX
10
17
5
0
1
33
Alnylam Pharmaceuticals Inc
ALNY
7
17
8
0
0
32
AbbVie Inc
ABBV
8
18
6
0
0
32
Gilead Sciences Inc
GILD
7
18
6
0
0
31
Merck & Co Inc
MRK
7
16
8
0
0
31
Neurocrine Biosciences Inc
NBIX
13
14
4
0
0
31
Bristol-Myers Squibb Co
BMY
5
6
18
1
0
30
Financial Forecasting
Based on analysts' estimates, ACIU EPS is projected to reach -0.195 in FY2026Q3, following reported EPS of 0.022 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.20
-0.18
-0.13
-0.20
-0.12
Actual
-0.18
-0.19
0.02
--
--
Surprise
+12.06%
-1.85%
+116.32%
--
--
FAQs
What is AC Immune SA's expected revenue for the next quarter?
AC Immune SA's expected revenue is 245.54K.
What is AC Immune SA's price target?
Analysts forecast that AC Immune SA's price target is USD 9.11, with the highest forecast at USD 12.00 and the lowest forecast at USD 5.40.
How have AC Immune SAACIU's recent earnings per share performed?
The market expectation was USD 0.02, while AC Immune SAACIU's earnings per share (EPS) for the previous quarter was USD -0.19. EPS for the next quarter is expected at USD -0.20.
What is the analyst rating for AC Immune SA?
Based on the ratings of AC Immune SA's stock from 4 analysts, most analysts support a STRONG BUY trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as STRONG BUY. Please note that this is not trading advice. You still need to conduct your own analysis.